Raub Brock Capital Management’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-2,355
| Closed | -$292K | – | 48 |
|
|
2023
Q4 | $292K | Buy |
+2,355
| New | +$292K | 0.06% | 60 |
|
|
2023
Q3 | – | Sell |
-1,980
| Closed | -$254K | – | 64 |
|
|
2023
Q2 | $254K | Hold |
1,980
| – | – | 0.05% | 63 |
|
|
2023
Q1 | $230K | Hold |
1,980
| – | – | 0.04% | 63 |
|
|
2022
Q4 | $224K | Buy |
+1,980
| New | +$224K | 0.05% | 60 |
|
|
2022
Q2 | – | Sell |
-1,980
| Closed | -$253K | – | 70 |
|
|
2022
Q1 | $253K | Sell |
1,980
-800
| -29% | -$102K | 0.04% | 66 |
|
|
2021
Q4 | $380K | Hold |
2,780
| – | – | 0.06% | 45 |
|
|
2021
Q3 | $380K | Hold |
2,780
| – | – | 0.06% | 45 |
|
|
2021
Q2 | $297K | Hold |
2,780
| – | – | 0.05% | 41 |
|
|
2021
Q1 | $250K | Hold |
2,780
| – | – | 0.04% | 56 |
|
|
2020
Q4 | $257K | Buy |
+2,780
| New | +$257K | 0.04% | 50 |
|